Drug Shortage Report for ACT PIOGLITAZONE
Report ID | 108625 |
Drug Identification Number | 02302896 |
Brand name | ACT PIOGLITAZONE |
Common or Proper name | PIOGLITAZONE 45MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PIOGLITAZONE |
Strength(s) | 45MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A10BG |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-11 |
Estimated end date | 2022-04-30 |
Actual end date | 2022-04-20 |
Shortage status | Resolved |
Updated date | 2022-04-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v40 | 2022-04-21 | French | Compare |
v39 | 2022-04-21 | English | Compare |
v38 | 2022-04-08 | French | Compare |
v37 | 2022-04-08 | English | Compare |
v36 | 2022-03-31 | French | Compare |
v35 | 2022-03-31 | English | Compare |
v34 | 2022-03-17 | French | Compare |
v33 | 2022-03-17 | English | Compare |
v32 | 2022-03-03 | French | Compare |
v31 | 2022-03-03 | English | Compare |
v30 | 2022-02-04 | French | Compare |
v29 | 2022-02-04 | English | Compare |
v28 | 2021-12-22 | French | Compare |
v27 | 2021-12-22 | English | Compare |
v26 | 2021-11-25 | French | Compare |
v25 | 2021-11-25 | English | Compare |
v24 | 2021-10-21 | French | Compare |
v23 | 2021-10-21 | English | Compare |
v22 | 2021-09-16 | French | Compare |
v21 | 2021-09-16 | English | Compare |